^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OncoScan™ CNV Plus Assay

    Company:
    Thermo Fisher Scientific
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    The OncoScan CNV Plus Assay is a whole-genome copy number microarray-based assay that enables the detection of relevant copy number variations (CNVs) such as copy number gain and loss, loss of heterozygosity (LOH), copy neutral loss of heterozygosity (cnLOH), ploidy, allele specific changes, break point determination, mosaicism, clonal heterogeneity, and chromothripsis, as well as a panel of driver somatic mutations. Key features of the OncoScan CNV Assay include: Whole-genome copy number analysis; Somatic mutation panel—covering 64 mutations in 9 genes (BRAF, EGFR, IDH1 and 2, KRAS, NRAS, PIK3CA, PTEN, and TP53)."
    Cancer:
    Brain Cancer
    Gene:
    BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), FGFR1 (Fibroblast growth factor receptor 1), HER-2 (Human epidermal growth factor receptor 2), IDH1 (Isocitrate dehydrogenase (NADP(+)) 1), IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2)
    See More ...
    Method:
    MicroArray